{
    "nctId": "NCT00413491",
    "briefTitle": "National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations",
    "officialTitle": "National Screening i Danmark Med MR-scanning af Brystet Kontra Klinisk Mammografi Hos Kvinder Der er b\u00e6rere af Risikogivende BRCA1 Eller BRCA2 Mutationer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Diagnostic outcome of a yearly screening with MR versus combined mammography and ultrasound of the breast measured by accuracy, sensitivity, specificity, positive and negative predictive values.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women tested positive of BRCA1 or BRCA2 gene mutations\n* referred for screening\n* aged 25 - 70 years\n\nExclusion Criteria:\n\n* general contraindications for MR\n* pregnant or lactating\n* men\n* bilateral mastectomy\n* ongoing treatment with chemotherapy\n* metastatic breast cancer\n* previous breast surgery less than 6 months before MR\n* previous radiation therapy of the breast less than 1 year before\n* incapable of managing her own affairs",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}